OTCMKTS:MAQAF - Atlas Arteria Group Stock Price, News, & Analysis

$5.39
+0.20 (+3.85 %)
(As of 06/18/2019 04:00 PM ET)
Today's Range
$5.39
Now: $5.39
$5.39
50-Day Range
$4.99
MA: $5.01
$5.19
52-Week Range
$4.27
Now: $5.39
$5.39
Volume110 shs
Average Volume495 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Atlas Arteria Limited invests in infrastructure and non-infrastructure assets. It holds a 13.4% interest in TRIP II, the concessionaire for Dulles Greenway toll road located in northern Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited is based in Sydney, Australia.

Industry, Sector and Symbol

Industry Infrastructure Operations
Sub-IndustryN/A
SectorIndustrials
Current SymbolOTCMKTS:MAQAF
CUSIPN/A
CIKN/A
Phone61 2 8232 7455

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive MAQAF News and Ratings via Email

Sign-up to receive the latest news and ratings for MAQAF and its competitors with MarketBeat's FREE daily newsletter.

Atlas Arteria Group (OTCMKTS:MAQAF) Frequently Asked Questions

What is Atlas Arteria Group's stock symbol?

Atlas Arteria Group trades on the OTCMKTS under the ticker symbol "MAQAF."

What is the consensus analysts' recommendation for Atlas Arteria Group?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Atlas Arteria Group in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Atlas Arteria Group.

Has Atlas Arteria Group been receiving favorable news coverage?

Media stories about MAQAF stock have been trending positive this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Atlas Arteria Group earned a media sentiment score of 2.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the near term. View News Stories for Atlas Arteria Group.

Who are some of Atlas Arteria Group's key competitors?

Who are Atlas Arteria Group's key executives?

Atlas Arteria Group's management team includes the folowing people:
  • Mr. Graeme Francis Bevans, CEO & Director (Age 61)
  • Ms. Nadine Lennie, Chief Financial Officer (Age 46)
  • Mr. Vincent Portal-Barrault, Chief Operating Officer
  • Phillipa Chen, Head of Investor Relations
  • Mr. Clayton John McCormack BCom, LLB, Company Sec. & Gen. Counsel

How do I buy shares of Atlas Arteria Group?

Shares of MAQAF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Atlas Arteria Group's stock price today?

One share of MAQAF stock can currently be purchased for approximately $5.39.

What is Atlas Arteria Group's official website?

The official website for Atlas Arteria Group is http://www.atlasarteria.com/.

How can I contact Atlas Arteria Group?

The company can be reached via phone at 61 2 8232 7455.


MarketBeat Community Rating for Atlas Arteria Group (OTCMKTS MAQAF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  4 (Vote Outperform)
Underperform Votes:  4 (Vote Underperform)
Total Votes:  8
MarketBeat's community ratings are surveys of what our community members think about Atlas Arteria Group and other stocks. Vote "Outperform" if you believe MAQAF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MAQAF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel